Verisante Technology, Inc. is a medical device company, which is engaged in development, regulatory, production and commercialization of skin cancer detection systems. Its products include verisante aura and verisante core. The verisante aura is a multimodality imaging and spectroscopy system designed to aid in the early detection of skin cancer. The verisante core is designed to aid in the early detection of other cancers, which includes lung, colon and cervical. verisante technology was founded by Thomas A. Braun on March 7, 2006 and is headquartered in Vancouver, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company